These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Generation of stable cell clones expressing mixtures of human antibodies. de Kruif J; Kramer A; Nijhuis R; van der Zande V; den Blanken R; Clements C; Visser T; Keehnen R; den Hartog M; Throsby M; Logtenberg T Biotechnol Bioeng; 2010 Aug; 106(5):741-50. PubMed ID: 20564612 [TBL] [Abstract][Full Text] [Related]
3. Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market. Huang CJ; Lowe AJ; Batt CA Appl Microbiol Biotechnol; 2010 Jun; 87(2):401-10. PubMed ID: 20422181 [TBL] [Abstract][Full Text] [Related]
4. The emerging therapeutic role of antibody mixtures. Robak T Expert Opin Biol Ther; 2013 Jul; 13(7):953-8. PubMed ID: 23646883 [TBL] [Abstract][Full Text] [Related]
5. Single-batch production of recombinant human polyclonal antibodies. Nielsen LS; Baer A; Müller C; Gregersen K; Mønster NT; Rasmussen SK; Weilguny D; Tolstrup AB Mol Biotechnol; 2010 Jul; 45(3):257-66. PubMed ID: 20306237 [TBL] [Abstract][Full Text] [Related]
9. Recombinant antibody libraries and selection technologies. Zhou H; Zhang YL; Lu G; Ji H; Rodi CP N Biotechnol; 2011 Sep; 28(5):448-52. PubMed ID: 21477669 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic antibody production technologies: molecules, applications, expression and purification. Humphreys DP; Glover DJ Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956 [TBL] [Abstract][Full Text] [Related]
11. Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use. Frandsen TP; Naested H; Rasmussen SK; Hauptig P; Wiberg FC; Rasmussen LK; Jensen AM; Persson P; Wikén M; Engström A; Jiang Y; Thorpe SJ; Förberg C; Tolstrup AB Biotechnol Bioeng; 2011 Sep; 108(9):2171-81. PubMed ID: 21495017 [TBL] [Abstract][Full Text] [Related]
12. Development of mass spectrometry based techniques for the identification and determination of compositional variability in recombinant polyclonal antibody products. Persson P; Engström A; Rasmussen LK; Holmberg E; Frandsen TP Anal Chem; 2010 Sep; 82(17):7274-82. PubMed ID: 20690610 [TBL] [Abstract][Full Text] [Related]
13. Aggregates in monoclonal antibody manufacturing processes. Vázquez-Rey M; Lang DA Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193 [TBL] [Abstract][Full Text] [Related]
14. High-level expression of full-length antibodies using trans-complementing expression vectors. Bianchi AA; McGrew JT Biotechnol Bioeng; 2003 Nov; 84(4):439-44. PubMed ID: 14574701 [TBL] [Abstract][Full Text] [Related]
15. Automated in situ measurement of cell-specific antibody secretion and laser-mediated purification for rapid cloning of highly-secreting producers. Hanania EG; Fieck A; Stevens J; Bodzin LJ; Palsson BØ; Koller MR Biotechnol Bioeng; 2005 Sep; 91(7):872-6. PubMed ID: 15937942 [TBL] [Abstract][Full Text] [Related]
16. Antibody engineering and modification technologies. Filpula D Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589 [TBL] [Abstract][Full Text] [Related]
17. Technological progresses in monoclonal antibody production systems. Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321 [TBL] [Abstract][Full Text] [Related]
18. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies. Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745 [TBL] [Abstract][Full Text] [Related]